{"id":"W4407224567","doi":"10.1111/jdv.20581","title":"Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; University of Calgary; Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"LEO Pharma; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sun Pharma; Biogen; Sanofi; Amgen; Pfizer","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Drug; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728808,0.0002460592,0.0008286565,0.0004167147,0.0003440217,0.0008976759,0.0003210767,0.001085359,0.001494342],"category_scores_gemma":[0.004584852,0.0001409406,0.0007927253,0.0009041801,0.0003487417,0.000734681,0.0002143242,0.0009953344,0.0002655807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001341179,"about_ca_system_score_gemma":0.0004615121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001120416,"about_ca_topic_score_gemma":0.001690171,"domain_scores_codex":[0.99882,0.0006136401,0.0001356741,0.0001555432,0.000130961,0.0001441622],"domain_scores_gemma":[0.9956527,0.002500435,0.0007263303,0.0001783088,0.0004066091,0.000535559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.219182,0.003588439,0.6268767,0.001061357,0.004069454,0.005214744,0.0006931401,0.0006755221,0.002986735,0.0006221895,0.007009355,0.1280204],"study_design_scores_gemma":[0.01905088,0.05206708,0.8901239,0.000390502,0.006095319,0.01163779,0.001769597,0.002175508,0.001228103,0.0007591855,0.01456157,0.0001404786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888,0.007529053,0.00007269486,0.001671977,0.0001934455,0.00003404495,0.0003564573,0.000002619368,0.001339643],"genre_scores_gemma":[0.996398,0.001457634,0.0001223693,0.001123314,0.0002637623,0.00003176837,0.0003111177,0.000001242624,0.0002908309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001728808,"threshold_uncertainty_score":0.009730995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02247603674056011,"score_gpt":0.3003816035527008,"score_spread":0.2779055668121407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}